Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
XCUR — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.24

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.7

Target Price

10.33

Analyst Recom

1

Performance Q

-22.38

Upside

-456.2%

Beta

3.55

Ticker: XCUR




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23XCUR3.59N/AN/A0
2026-04-24XCUR3.46N/AN/A0
2026-04-27XCUR3.58N/AN/A0
2026-04-28XCUR3.32N/AN/A0
2026-04-29XCUR3.21N/AN/A0
2026-04-30XCUR3.27N/AN/A0
2026-05-01XCUR3.22N/AN/A0
2026-05-04XCUR3.26N/AN/A0
2026-05-05XCUR3.44N/AN/A0
2026-05-06XCUR3.4N/AN/A0
2026-05-07XCUR3.24N/AN/A0
2026-05-08XCUR3.3499N/AN/A0
2026-05-11XCUR3.28N/AN/A0
2026-05-12XCUR3.14N/AN/A0
2026-05-13XCUR3.08N/AN/A0
2026-05-14XCUR3.15N/AN/A0
2026-05-15XCUR2.83N/AN/A0
2026-05-18XCUR2.92N/AN/A0
2026-05-19XCUR2.9N/AN/A0
2026-05-20XCUR2.99N/AN/A0
2026-05-21XCUR2.76N/AN/A0
2026-05-22XCUR2.81N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23XCUR3.59- - -
2026-04-24XCUR3.47- - -
2026-04-27XCUR3.58- - -
2026-04-28XCUR3.32- - -
2026-04-29XCUR3.23- - -
2026-04-30XCUR3.27- - -
2026-05-01XCUR3.27- - -
2026-05-04XCUR3.30- - -
2026-05-05XCUR3.47- - -
2026-05-06XCUR3.44- - -
2026-05-07XCUR3.39- - -
2026-05-08XCUR3.25- - -
2026-05-11XCUR3.29- - -
2026-05-12XCUR3.24- - -
2026-05-13XCUR3.00- - -
2026-05-14XCUR3.19- - -
2026-05-15XCUR2.94- - -
2026-05-18XCUR3.00- - -
2026-05-19XCUR2.81- - -
2026-05-20XCUR3.00- - -
2026-05-21XCUR2.73- - -
2026-05-22XCUR2.70- - -
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23XCUR-50.00-30.261.37
2026-04-24XCUR-50.00-30.261.37
2026-04-27XCUR-50.00-30.141.38
2026-04-28XCUR-50.00-30.141.38
2026-04-29XCUR-50.00-30.141.38
2026-04-30XCUR-50.00-30.141.38
2026-05-01XCUR-50.00-30.141.38
2026-05-04XCUR-50.00-30.461.38
2026-05-05XCUR-50.00-30.461.38
2026-05-06XCUR-49.99-30.461.38
2026-05-07XCUR-50.00-30.461.38
2026-05-08XCUR-50.00-30.461.38
2026-05-11XCUR-50.00-30.131.38
2026-05-12XCUR-50.00-30.131.24
2026-05-13XCUR-50.00-30.131.24
2026-05-14XCUR-50.00-30.131.24
2026-05-15XCUR-50.00-30.131.24
2026-05-18XCUR-50.00-22.871.24
2026-05-19XCUR-50.00-22.871.24
2026-05-20XCUR-50.00-22.871.24
2026-05-21XCUR-50.00-22.871.24
2026-05-22XCUR-50.00-22.871.24
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

-50

Institutional Transactions

-22.87

Beta

3.55

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

11

Growth Score

Sentiment Score

16

Actual DrawDown %

99.1

Max Drawdown 5-Year %

-99.4

Target Price

10.33

P/E

Forward P/E

PEG

P/S

P/B

4.56

P/Free Cash Flow

EPS

-0.77

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.85

Return on Equity vs Sector %

-153

Return on Equity vs Industry %

-137.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

XCUR Healthcare
$2.81
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
20/20
Pullback
17/25
Volume
7/15
Valuation
12/20
TP/AR
2/10
Options
0/10
RSI
33.9
Range 1M
9.4%
Sup Dist
5.7%
🚀
Momentum Growth
Ride accelerating trends
N/A
16 /100
WEAK
Momentum
8/25
Growth
8/30
Estimates
0/20
Inst/Vol
0/15
Options
0/10
EPS Yr
0%
EPS NY
0%
52W%
1.2%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +267.6% upside
Quality
3/30
Valuation
16/30
Growth
3/25
Stability
4/10
LT Trend
4/5
Upside
+267.6%
Quality
11
Exicure, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 8
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
XCUR

Latest News

Caricamento notizie per XCUR
stock quote shares XCUR – Exicure Inc. Stock Price stock today
news today XCUR – Exicure Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch XCUR – Exicure Inc. yahoo finance google finance
stock history XCUR – Exicure Inc. invest stock market
stock prices XCUR premarket after hours
ticker XCUR fair value insiders trading